Delivery Order SPE2DB20D3505-SPE2DB22FT8F4
- Not listed
- This federal contract award is a Delivery Order worth $1,496.81 from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- This federal contract award is for the delivery of Timolol 0.5% Gel-Solution, a pharmaceutical product, with a ceiling value of $4,786.14. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order (DO) type with a Firm Fixed Price (FFP) pricing mechanism. The contract has an ultimate completion date of April 25, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.84, is for the delivery of Timolol Maleate 0.5% eye drops in 60 count unit dose packaging. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09, UEI: KABZK8W6PQT3) is for the supply of Timolol 0.5% Gel-Solution 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $4,941.61 and is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,800.72 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 29, 2025, just one day after the award date of October 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award, valued at $4,156.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4565178283 - TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, and has an ultimate completion date of July 18, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award, valued at $24,421.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye drop medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $4,424.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, with an ultimate completion date of November 7, 2025. This non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,617.93, is for the delivery of Timolol 0.25% Gel-Solution 5ML, a prescription eye drop medication. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT8F4Delivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Timolol 0.5% gel-solution medical products to support military healthcare programs. The $3,005.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities and veterans' healthcare programs globally. This contract award, valued at $3,005.89, is part of the company's broader efforts to support the critical medical needs of the Department of Defense. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 5/18/22 |